Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
F 3.25 0.93% 0.03
CEMI closed up 0.93 percent on Friday, May 14, 2021, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CEMI trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Spinning Top Other 0.93%
Lower Bollinger Band Walk Weakness 0.93%
Lower Bollinger Band Touch Weakness 0.93%
Oversold Stochastic Weakness 0.93%
Stochastic Buy Signal Bullish -1.22%
Lower Bollinger Band Walk Weakness -1.22%
Inside Day Range Contraction -1.22%
Older End-of-Day Signals for CEMI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Chembio Diagnostics, Inc. Description

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Immunology Immune System Infectious Diseases Antibodies Technology Products Antibody Multiplex Medical Tests Diagnostic Tests Public Health HIV HIV/Aids Ortho Clinical Diagnostics Retail Establishments Diagnosis Of Hiv/Aids Diagnostic Systems Medford

Is CEMI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 12.2
52 Week Low 3.01
Average Volume 6,135,222
200-Day Moving Average 4.99
50-Day Moving Average 3.96
20-Day Moving Average 3.66
10-Day Moving Average 3.45
Average True Range 0.28
ADX 17.88
+DI 14.07
-DI 27.37
Chandelier Exit (Long, 3 ATRs ) 3.32
Chandelier Exit (Short, 3 ATRs ) 3.95
Upper Bollinger Band 4.24
Lower Bollinger Band 3.09
Percent B (%b) 0.14
BandWidth 31.46
MACD Line -0.24
MACD Signal Line -0.20
MACD Histogram -0.0337
Fundamentals Value
Market Cap 65.57 Million
Num Shares 20.2 Million
EPS -0.73
Price-to-Earnings (P/E) Ratio -4.45
Price-to-Sales 3.36
Price-to-Book 3.17
PEG Ratio -0.48
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.60
Resistance 3 (R3) 3.59 3.48 3.54
Resistance 2 (R2) 3.48 3.39 3.48 3.52
Resistance 1 (R1) 3.36 3.33 3.31 3.37 3.50
Pivot Point 3.25 3.25 3.22 3.25 3.25
Support 1 (S1) 3.13 3.16 3.08 3.14 3.00
Support 2 (S2) 3.02 3.10 3.02 2.98
Support 3 (S3) 2.90 3.02 2.96
Support 4 (S4) 2.91